MedPath

Investigation of the safety and efficacy of long term administration of eszopiclone in insomnia patients

Not Applicable
Conditions
Insomnia
Registration Number
JPRN-jRCT1080222868
Lead Sponsor
Eisai Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
400
Inclusion Criteria

Patients who have completed the preceding drug use result surveillance study of Lunesta and need to continue Lunesta

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath